Drugs / Sabin Inactivated Poliovirus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04264546 | Nov 2017 → Mar 2018 | poliomyelitis | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sabin Inactivated Poliovirus Vaccine | “A Phase Ib Study to Evaluate the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Vero Cell)” NCT04264546 ↗ |
| Known as | sIPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04264546 ↗ |
| Modality | Vaccine | “A Phase Ib Study to Evaluate the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Vero Cell)” NCT04264546 ↗ |
| Route | Intramuscular | “One intramuscular injection of the investigational vaccine (0.5 ml)” NCT04264546 ↗ |